green
Positive treatment
4.6 score
Treatment trajectory · 1981 → 2026 · click a year to view as-of
1981
2003
2026
Top citers, strongest first. 6 distinct citers.
How cited ↗
cited
Cited "but see"
Jaymar-Ruby, Inc. v. Federal Trade Commission
But see Bristol Laboratories Div. v. Staats, 620 F.2d 17 (2nd Cir. 1980), affirmed by an equally divided Court, 451 U.S. -, 101 S.Ct. 2037 , 68 L.Ed.2d 343 (1981).
discussed
Cited "see"
State v. Savastano
See City of Klamath Falls v. Winters, 289 Or 757 , 769-70 n 10, 619 P2d 217 (1980), appeal dismissed, 451 US 964 , 101 S Ct 2037 , 68 L Ed 2d 343 (1981) (explaining that “[t]his court has consistently held that the scope of these two provisions is the same”).
examined
Cited "see"
United States v. John Pimentel and Duroyd Manufacturing Co., Inc.
(3×)
See Bristol Laboratories Division of Bristol-Myers Co. v. Staats, 428 F.Supp. 1388, 1391 (S.D.N.Y.1977), aff'd on opinion below, 620 F.2d 17 (2d Cir.1980), aff'd by equally divided court, 451 U.S. 400 , 101 S.Ct. 2037 , 68 L.Ed.2d 184 (1981); 10 U.S.C. §§ 2306 (f)(1), (3) and 2313(a)(1), (b).
cited
Cited "see"
Sanders v. United States National Bank
See City of Klamath Falls v. Winters, 289 Or. 757 , 619 P.2d 217 (1980), appeal dismissed 451 U.S. 964 , 101 S.Ct. 2037 , 68 L.Ed.2d 343 (1981).
discussed
Cited "see"
Bowsher v. Merck & Co.
(2×)
See Bristol Laboratories Division of Bristol-Myers Co. v. Staats, 428 F. Supp. 1388 (SDNY 1977), aff’d, 620 F. 2d 17 (CA2 1980), aff’d by an equally divided Court, 451 U. S. 400 (1981).
discussed
Cited "see"
Merck & Co., Inc. v. Elmer B. Staats, Comptroller Merck & Co., Inc. v. Elmer B. Staats, Comptroller
See Staats v. Bristol Laboratories Division of Bristol-Myers Co., 428 F.Supp. 1388 (S.D.N.Y.1977), 620 F.2d 17 (2d Cir. 1980), aff'd by evenly divided court, --- U.S. ----, 101 S.Ct. 2037 , 68 L.Ed.2d 343 (1981); SmithKline Corp. v. Staats, 483 F.Supp. 712 (E.D.Pa.1980), appeal pending No. 80-1464 (3d Cir. Mar. 19, 1980), conditional petition for certiorari before judgment denied December 8, 1980, 449 U.S. 1038 , 101 S.Ct. 619 , 66 L.Ed.2d 502 (1980); Eli Lilly & Co. v. Staats, 574 F.2d 904 (7th Cir. 1978), cert. denied, 439 U.S. 959 , 99 S.Ct. 362 , 58 L.Ed.2d 351 (1978); United States v. Abb…
Retrieving the full opinion text from the archive…
STAATS, COMPTROLLER GENERAL OF THE UNITED STATES, ET AL.
v.
BRISTOL LABORATORIES DIVISION OF BRISTOL-MYERS CO.
v.
BRISTOL LABORATORIES DIVISION OF BRISTOL-MYERS CO.
80-264.
Supreme Court of the United States.
Apr 29, 1981.
Per Curiam.
Cited by 3 opinions | Published
CERTIORARI TO THE UNITED STATES COURT OF APPEALS FOR THE SECOND CIRCUIT.
Mark I. Levy argued the cause for petitioners. With him on the briefs were Solicitor General McCree, Acting Assistant Attorney General Martin, Deputy Solicitor General Geller, Michael Kimmel, Robert Kaplan, and Milton J. Socolar.
Gilbert H. Weil argued the cause for respondent. With him on the brief was Robert L. Sherman.[*]
PER CURIAM.
The judgment is affirmed by an equally divided Court.
JUSTICE STEWART took no part in the consideration or decision of this case.
[*] Philip Lacovara, Ronald A. Stern, Stanley L. Temko, Charles Lister, and Clare Dalton filed a brief for Merck & Co., Inc., et al. as amici curiae urging affirmance.